Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

The latest news and analysis of the pharmaceutical and biotech business landscape. Including staff moves, product launches, acquisitions, mergers, collaborations and licensing agreements.

Showing 15 posts of 2378 posts found.

Merck completes acquisition of Harpoon Therapeutics for $650m

March 12, 2024 Business Services Harpoon Therapeutics, Merck, Oncology, lung cancer

Merck, known as MSD outside of the US and Canada, has announced that it has completed the acquisition of Harpoon …
News

Johnson & Johnson acquires Ambrx Biopharma for approximately $2bn

March 11, 2024 Business Services ADCs, Ambrx Biopharma, J&J, Johnson & Johnson, Oncology, acquisition

Johnson & Johnson (J&J) has announced that it has successfully completed its acquisition of Ambrx Biopharma in an all-cash merger …
News

Aspire Pharma acquires Cenoté Pharma

March 11, 2024 Business Services Aspire Pharma, Cenoté Pharma, Pharmacy, acquisition

Aspire Pharma has announced that it has successfully acquired Cenoté Pharma as part of its plan to supplement its growth …
News

Domainex opens new Biology Centre of Excellence in Cambridge, UK

February 14, 2024 Business Services Pharmacy, domainex, facility

Domainex has announced that it has opened a new Biology Centre of Excellence at the Unity Campus at Pampisford, Cambridge, …
News
brano-mm1vipqd0oa-unsplash

Jazz Pharmaceuticals enters agreement to acquire rights to KRAS inhibitor programme from Redx Pharma

February 7, 2024 Business Services Pharmacy, RedX Pharma, acquisition, jazz pharmaceuticals

Jazz Pharmaceuticals and Redx Pharma have announced that the companies have signed a definitive agreement under which Jazz will acquire …
News

Novartis to acquire MorphoSys AG for €2.7bn

February 6, 2024 Business Services Novartis, Pharmacy, acquisition, morphosys

Novartis has announced that it has entered an agreement to acquire MorphoSys AG for €2.7bn, or €68 per share. The …
News

Zuellig Pharma acquires Cialis and Alimta from Eli Lilly in certain ASEAN markets

February 5, 2024 Business Services Cialis, Eli Lilly, Pharmacy, Zuellig Pharma, acquisition

Zuellig Pharma has announced that it has completed the acquisition of two brands Cialis (Tadalafil) and Alita (Pemetrexed) from Eli …
News
louis-reed-pwckf7l4-no-unsplash_5

Regeneron forms Regeneron Cell Medicines with acquisition of 2seventy bio

January 31, 2024 Business Services 2seventy bio, Pharmacy, Regeneron, Regeneron Cell Medicines, acquisition

Regeneron Pharmaceuticals has announced the formation of Regeneron Cell Medicines based on an agreement with 2seventy bio to acquire the …
News

Oxford Biomedica acquires ABL Europe for €15m

January 30, 2024 Business Services ABL Europe, Oxford BioMedica, Pharmacy, acquisition

Oxford Biomedica has announced that it has completed the acquisition of ABL Europe from Institut Mérieux. This follows announcements on …
News

Futura Medical appoints Roy Davis as non-executive director

January 25, 2024 Business Services Futura Medical, Roy Davis, appointment, non-executive director

Futura Medical has announced the appointment of Roy Davis as non-executive director effective immediately. Roy has extensive commercial experience in …
Appointment

Cellular Origins appoints Peter Crossley as chief operating officer

January 25, 2024 Business Services Cellular Origins, Peter Crossley, appointment, chief operating officer

Cellular Origins, a TTP Company, has announced that it has appointed Peter Crossley as chief operating officer (COO). Peter brings …
Appointment

BenevolentAI appoints Dr Joerg Moeller as CEO

January 25, 2024 Business Services BenevolentAI, CEO, Dr Joerg Moeller, appointment

BenevolentAI has announced that it has appointed Dr Joerg Moeller MD PhD as chief executive officer and executive board member …
Appointment

Sanofi to acquire Inhibrx for approximately $1.7bn

January 23, 2024 Business Services Inhibrx, Rare Diseases, Sanofi, acquisition

Sanofi and Inhibrx, Inc have announced that they have entered into a definitive agreement for Sanofi to acquire Inhibrx following …
News

Qlucore and Sahlgrenska Hospital sign agreement for ALL diagnosis software

January 17, 2024 Business Services Oncology, Qlucore, Sahlgrenska Hospital, acute lymphoblastic leukaemia, leukaemia

Qlucore has announced that it has entered into an agreement with Sahlgrenska Hospital, in Gothenberg, Sweden. This agreement means the …
News

Merck to acquire Harpoon Therapeutics for approximately $680m

January 10, 2024 Business Services Harpoon Therapeutics, MSD, Merck, Oncology, acquisition

Merck (known as MSD outside of the US and Canada) and Harpoon Therapeutics have announced that they have entered a …
News

Latest content

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024

Sarepta Therapeutics gains expanded FDA approval for DMD treatment

June 21, 2024

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024

EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment

June 19, 2024